CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Intravenous Magnesium Sulfate Infusions for the Management of Pregnancy-Related Toxemia, Hypomagnesemia/Tetany, or Cardiac Dysrrhythmias: Clinical Review of Safety and Effectiveness and Guidelines for Use

Last updated: June 4, 2008
Product Line: Rapid Response
Result type: Report


  1. What is the clinical safety and effectiveness of intravenous infusions of magnesium sulfate (MgSO4) in adult patients for pregnancy-related toxemia, hypomagnesemia/tetany, and/or cardiac dysrrhythmias?
  2. What are the guidelines for use of intravenous infusions of MgSO4 in adult patients?